This is the authors' abstract. We don't add key points for this paper.
This review addresses interferon (IFN) signaling in immune cells and the tumor microenvironment (TME) and examines how this affects cancer progression. The data reveal that IFNs exert dual roles in cancers, dependent on the TME, exhibiting both anti-tumor activity and promoting cancer progression. We discuss the abnormal IFN signaling induced by cancerous cells that alters immune responses to permit their survival and proliferation.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Ζαννίκου et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: